Rare Brain Tumor Responds to Targeted Tumor Treatment with ‘Unprecedented’ Success
Mass General Cancer Center’s precision medicine approach resulted in 91 percent reduction in tumor size, with all 15 patients who received one or more cycles of therapy responding to treatment.